Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Polyploid

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Polyploid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dijkhuis, AJ; Jacobs, S; Kamps, W; Klappe, K; Kok, JW; Kroesen, BJ; Sietsma, H	1

Other Studies

1 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Polyploid

Article	Year
PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy. Molecular cancer therapeutics, 2006, Volume: 5, Issue:3 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Ceramides; Cyclin-Dependent Kinase 2; Down-Regulation; Drug Resistance, Neoplasm; Fatty Acids, Monounsaturated; Lipid Metabolism; Mice; Morpholines; Neuroblastoma; Paclitaxel; Polyploidy; Sphingolipids	2006

Article

Year

PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy.

Molecular cancer therapeutics, 2006, Volume: 5, Issue:3

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Ceramides; Cyclin-Dependent Kinase 2; Down-Regulation; Drug Resistance, Neoplasm; Fatty Acids, Monounsaturated; Lipid Metabolism; Mice; Morpholines; Neuroblastoma; Paclitaxel; Polyploidy; Sphingolipids

2006